Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talmadge

Showing results (371-380 of 519) with videos related to

Pageof 52
Sort By:
Cancer Research|March 1, 1986
Therapy of autochthonous skin cancers in mice with intravenously injected liposomes containing muramyltripeptideJ E Talmadge, B F Lenz, R Klabansky, et al.
Molecular and Cellular Biology|January 1, 1985
NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude miceU P Thorgeirsson, T Turpeenniemi-Hujanen, J E Williams, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 6, 1998
Impact of resistance exercise during bed rest on skeletal muscle sarcopenia and myosin isoform distributionM M Bamman, M S Clarke, D L Feeback, et al.
Radiology|July 1, 2005
Idiopathic interstitial pneumonias: CT featuresDavid A Lynch, William D Travis, Nestor L Müller, et al.
The Journal of Experimental Medicine|November 1, 1984
Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liverR H Wiltrout, B J Mathieson, J E Talmadge, et al.
BMC Cell Biology|July 30, 2004
Calcineurin activation influences muscle phenotype in a muscle-specific fashionRobert J Talmadge, Jeffrey S Otis, Matthew R Rittler, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2S R Zhang, R R Salup, P E Urias, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 21, 2017
Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular JunctionsAhmad Khedraki, Eric J Reed, Shannon H Romer, et al.
Chest|June 11, 2004
Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosisHarold R Collard, Jay H Ryu, William W Douglas, et al.
Bone Marrow Transplantation|March 14, 2003
Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in miceS N Robinson, J M Chavez, V M Pisarev, et al.
Pageof 52

Showing results (371-380 of 519) with videos related to

Sort By:
Pageof 52
Cancer Research|March 1, 1986
Therapy of autochthonous skin cancers in mice with intravenously injected liposomes containing muramyltripeptideJ E Talmadge, B F Lenz, R Klabansky, et al.
Molecular and Cellular Biology|January 1, 1985
NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude miceU P Thorgeirsson, T Turpeenniemi-Hujanen, J E Williams, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 6, 1998
Impact of resistance exercise during bed rest on skeletal muscle sarcopenia and myosin isoform distributionM M Bamman, M S Clarke, D L Feeback, et al.
Radiology|July 1, 2005
Idiopathic interstitial pneumonias: CT featuresDavid A Lynch, William D Travis, Nestor L Müller, et al.
The Journal of Experimental Medicine|November 1, 1984
Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liverR H Wiltrout, B J Mathieson, J E Talmadge, et al.
BMC Cell Biology|July 30, 2004
Calcineurin activation influences muscle phenotype in a muscle-specific fashionRobert J Talmadge, Jeffrey S Otis, Matthew R Rittler, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2S R Zhang, R R Salup, P E Urias, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 21, 2017
Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular JunctionsAhmad Khedraki, Eric J Reed, Shannon H Romer, et al.
Chest|June 11, 2004
Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosisHarold R Collard, Jay H Ryu, William W Douglas, et al.
Bone Marrow Transplantation|March 14, 2003
Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in miceS N Robinson, J M Chavez, V M Pisarev, et al.
Pageof 52